CClinicalTrials.gg
CompletedNCT03403231INVENTUpdated Jul 25, 2023Results posted

INcreasing Veteran EngagemeNT to Prevent Diabetes (INVENT)

An interventional study of INVENT Secure Messaging Intervention in Prediabetes, sponsored by VA Office of Research and Development. Completed at 1 site in United States. Open to participants aged Up to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-07-25.

Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
144
Allocation
Randomized
Ages
Up to 75 Years
Sex
All
01

Study summary

This study will evaluate a VA MyHealtheVet Secure Messaging intervention that uses different intervention messaging strategies designed to increase engagement in behaviors to prevent type 2 diabetes.

The investigators will enroll 144 eligible Veterans into a 12-week MyHealtheVet Secure Messaging intervention. Eligible Veterans include those who are currently using MyHealtheVet secure messaging, meet inclusion/exclusion criteria, and have received an HbA1c test within the last 6 months that meets the ADA/CDC classification for prediabetes. Study participants will be surveyed about their engagement in behaviors to prevent TDM2 and mediators of this engagement. After completing a baseline survey, participants will be randomly assigned to receive different novel presentations of information about ways to prevent T2DM through both Secure Messaging and US Mail. The investigators will test the 5 presentations that each: (1) represent an innovative approach from behavioral economics or health psychology with great promise to increase engagement in behaviors to prevent T2DM among patients with prediabetes; and (2) have not been tested in this setting.

Read the detailed description

There is tremendous national enthusiasm for translating and disseminating efficacious strategies to prevent type 2 diabetes mellitus (T2DM). Yet, little attention has been devoted to how the investigators can better leverage the processes through which patients receive information about prevention of T2DM to better engage them in such prevention. Further, despite efforts to disseminate structured programs, many patients at high risk for developing T2DM may still be unable or unwilling to access them. In these cases, increasing patient engagement in individually directed lifestyle change or pharmacotherapy is critical. Strategies developed in the fields of behavioral economics and health psychology hold significant promise for improving Veteran engagement in each of these approaches. To date, however, these strategies have rarely been translated into real-world settings where they could benefit Veterans. This novel work will address this critical gap and could transform communication with Veterans about prevention in ways that will improve their health outcomes.

The following 5 strategies will be implemented in the weekly messages that study participants will receive: (1) tailoring to aspirations in life; (2) implementation intentions; (3) preference checklists; (4) urgency framing; (5) social norms. The investigators will implement these strategies alone and in combination in a 16-arm factorial design experiment.

02

Conditions studied

  • Prediabetes

Keywords

  • Veterans
  • Type 2 diabetes mellitus
  • Prediabetes
  • Secure Messaging
  • Health Promotion
  • Prevention and Control
  • Motivation
03

Who can participate

Ages eligible
Up to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. HbA1c test within the past 6 months that meets the ADA/CDC requirements for prediabetes.
  2. Currently registered in the VA's MyHealtheVet Secure Messaging System
  3. Receiving care within the Ann Arbor VA Healthcare System

Exclusion criteria

Exclusion Criteria:

  1. Completed more than 4 VA MOVE! classes in the last year (or other evidence of another recent weight loss program)
  2. Are trying to lose weight and are very physically active
  3. Are >75 years of age
  4. Are pregnant or plan to be
  5. Are taking Metformin
  6. Have participated in the FINDIT study (this study's predecessor under the same grant funding)
  7. Have been hospitalized or received rehab for stroke or myocardial infarction within past 6 months
  8. Have received chemotherapy for cancer in the past 6 months
  9. Self-report or have any International Classification of Diseases (ICD-9/10) codes for:

    • Diabetes
    • Dementia
    • Major functional limitations
    • Cirrhosis
    • Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage 4 chronic obstructive pulmonary disease (COPD)
    • End stage renal disease (ESRD)
    • New York Heart Association (NYHA) class III or IV congestive heart failure (CHF)
04

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Single (Investigator)
Enrollment
144 participants (actual)

Study arms

  • Active comparator
    Arm 1: Stock messages only

    Participants will only receive the stock messages that encourage following recommended behaviors for reducing the risk for developing diabetes.

    Behavioral: INVENT Secure Messaging Intervention

  • Experimental
    Arm 2: Urgency frame message strategy

    Participants will receive messages that encourage following recommended behaviors for reducing the risk for developing diabetes integrated with the urgency frame message strategy.

    Behavioral: INVENT Secure Messaging Intervention

  • Experimental
    Arm 3: Social norm message strategy

    Participants will receive messages that encourage following recommended behaviors for reducing the risk for developing diabetes integrated with the social norm messaging strategy.

    Behavioral: INVENT Secure Messaging Intervention

  • Experimental
    Arm 4: Urgency frame and social norm strategies

    Participants will receive messages that encourage following recommended behaviors for reducing the risk for developing diabetes integrated with both the urgency frame and social norm messaging strategies.

    Behavioral: INVENT Secure Messaging Intervention

  • Experimental
    Arm 5: Implementation Intentions and Urgency Frame

    Participants will receive messages that encourage following recommended behaviors for reducing the risk for developing diabetes integrated with both the implementation intentions and urgency frame messaging strategies.

    Behavioral: INVENT Secure Messaging Intervention

  • Experimental
    Arm 6: Implementation Intentions and Social Norm

    Participants will receive messages that encourage following recommended behaviors for reducing the risk for developing diabetes integrated with both the implementation intentions and social norm messaging strategies.

    Behavioral: INVENT Secure Messaging Intervention

  • Experimental
    Arm 7: Implementation Intentions, Urgency Frame & Social Norm

    Participants will receive messages that encourage following recommended behaviors for reducing the risk for developing diabetes integrated with the implementation intentions, urgency frame, and social norm messaging strategies.

    Behavioral: INVENT Secure Messaging Intervention

  • Experimental
    Arm 8: Implementation Intentions

    Participants will receive messages that encourage following recommended behaviors for reducing the risk for developing diabetes integrated with the implementation intentions messaging strategy.

    Behavioral: INVENT Secure Messaging Intervention

  • Experimental
    Arm 9: Preference Checklists and Urgency Frame

    Participants will receive messages that encourage following recommended behaviors for reducing the risk for developing diabetes integrated with both the preference checklists and urgency frame messaging strategies.

    Behavioral: INVENT Secure Messaging Intervention

  • Experimental
    Arm 10: Preference Checklists and Social Norms

    Participants will receive messages that encourage following recommended behaviors for reducing the risk for developing diabetes integrated with both the preference checklists and social norm messaging strategies.

    Behavioral: INVENT Secure Messaging Intervention

  • Experimental
    Arm 11: Preference Checklists, Urgency Frame & Social Norm

    Participants will receive messages that encourage following recommended behaviors for reducing the risk for developing diabetes integrated with the preference checklists, urgency frame, and social norm messaging strategies.

    Behavioral: INVENT Secure Messaging Intervention

  • Experimental
    Arm 12: Preference Checklists

    Participants will receive messages that encourage following recommended behaviors for reducing the risk for developing diabetes integrated with the preference checklists messaging strategy.

    Behavioral: INVENT Secure Messaging Intervention

  • Experimental
    Arm 13: Tailored Aspirations and Urgency Frame

    Participants will receive messages that encourage following recommended behaviors for reducing the risk for developing diabetes integrated with both the tailored aspirations and urgency frame messaging strategies.

    Behavioral: INVENT Secure Messaging Intervention

  • Experimental
    Arm 14: Tailored Aspirations and Social Norm

    Participants will receive messages that encourage following recommended behaviors for reducing the risk for developing diabetes integrated with both the tailored aspirations and social norm messaging strategies.

    Behavioral: INVENT Secure Messaging Intervention

  • Experimental
    Arm 15: Tailored Aspirations, Urgency Frame & Social Norm

    Participants will receive messages that encourage following recommended behaviors for reducing the risk for developing diabetes integrated with the tailored aspirations, urgency frame, and social norm messaging strategies.

    Behavioral: INVENT Secure Messaging Intervention

  • Experimental
    Arm 16: Tailored Aspirations

    Participants will receive messages that encourage following recommended behaviors for reducing the risk for developing diabetes integrated with the tailored aspirations messaging strategy.

    Behavioral: INVENT Secure Messaging Intervention

Interventions

  • BehavioralINVENT Secure Messaging Intervention

    We are proposing a 12 week schedule of weekly Secure Messages and monthly mailings for this intervention. Each study arm represents different combinations of messages a participant will receive.

05

What researchers measure

Primary outcomes

  1. Engagement in Recommended Behaviors to Prevent Type 2 Diabetes

    The investigators will use survey and medical record data to evaluate changes in participants' engagement in recommended behaviors to prevent type 2 diabetes.

    Time frame: 3 months

Secondary outcomes

  1. Motivation to Prevent Type 2 Diabetes

    The investigators will use survey data to evaluate mean change in motivation level to prevent diabetes between baseline and 3-months. The Treatment Self-Regulation Questionnaire (TSRQ) was included in the survey and respondents were asked about their level of motivation from 1 (Not at all motivated) to 10 (Highly motivated).

    Time frame: 3 months

  2. Importance of Preventing Type 2 Diabetes

    The investigators will use survey data to evaluate mean changes in level of importance of preventing diabetes from baseline to 3 months. The Treatment Self-Regulation Questionnaire (TSRQ) was included in the survey and respondents were asked about their level of perceived importance from 1 (Not at all important) to 10 (Extremely important).

    Time frame: 3 months

  3. Use of Medication for T2DM Prevention

    The investigators will use medical record data and survey data to evaluate whether participants began the use of medication for T2DM prevention from baseline to 3 months.

    Time frame: 3 months

  4. Perception for Risk for T2DM

    The investigators will use survey data to evaluate mean changes in perception of risk for T2DM from baseline to 3 months. The Adriaanse T2DM Risk Perception Scale, which was included in the survey, measured self-assessed risk perception from 0 denoting no choice of developing T2DM to 100 denoting absolute confidence in developing T2DM

    Time frame: 3 months

  5. Knowledge of Strategies to Prevent T2DM

    The investigators will use survey data to evaluate changes in knowledge of strategies to prevent Type 2 Diabetes between baseline and 3-month assessment. Respondents were given 3 open-ended questions to report things they could do to prevent diabetes. Each respective response to the 3 questions were coded and scored according to whether they indicated engagement in the following activities: weight loss, physical activity, use of metformin, or enrollment into a diabetes prevention program. Each question denoted with a positive response were coded with 1 whereas those that did not were coded as a 0. The three questions were summed into a final score ranging from 0 (no report of engagement in the aforementioned healthy activities) with the worst outcome to 3 (a report of 3 of the 4 aforementioned healthy activities) with the best outcome. The final scores were generated based on the mean difference between baseline and 3-month scores.

    Time frame: 3 months

  6. Participation in Weight-related Wellness Programs

    The investigators will use survey data to evaluate how many participants enrolled in weight-related wellness programs from baseline to 3 months.

    Time frame: 3 months

  7. Weight Loss Behaviors

    The investigators will use survey data to evaluate changes in weight loss behaviors at the 3-month post intervention assessment.

    Time frame: 3 months

  8. Physical Activity

    The investigators will use survey data to evaluate changes in physical activity after the 3-month post intervention assessment. The International Physical Activity Questionnaire - Short Form (IPAQ-SF) was used to measure physical activity change. Respondents were asked to report how many hours and minutes within the past week they completed of vigorous physical activity, moderate physical activity, and brisk walking. The total sum of minutes for these three questions were subsequently coded into a yes/no binary variable for whether respondents met a recommended 150 minutes of overall physical activity within 7 days of being assessed. The values provided reflect a proportion of respondents that met or exceeded the 150 minute threshold of overall physical activity based on the newly generated variable that combined total minutes of vigorous physical activity, moderate physical activity, and brisk walking.

    Time frame: 3 months

06

Results

Posted Jun 16, 2021

Participant flow

Veterans that met preliminary study eligibility criteria were mailed a letter about the study and were contacted by a Research Assistant 7-10 days later by phone to gauge their participation interest.

Participant flow — Overall Study
MilestoneArm 1: Stock Messages OnlyArm 2: Urgency Frame Message StrategyArm 3: Social Norm Message StrategyArm 4: Urgency Frame and Social Norm StrategiesArm 5: Implementation Intentions and Urgency FrameArm 6: Implementation Intentions and Social NormArm 7: Implementation Intentions, Urgency Frame & Social NormArm 8: Implementation IntentionsArm 9: Preference Checklists and Urgency FrameArm 10: Preference Checklists and Social NormsArm 11: Preference Checklists, Urgency Frame & Social NormArm 12: Preference ChecklistsArm 13: Tailored Aspirations and Urgency FrameArm 14: Tailored Aspirations and Social NormArm 15: Tailored Aspirations, Urgency Frame & Social NormArm 16: Tailored Aspirations
Started9999999999999999
Completed9999999999999999
Not completed0000000000000000

Outcome measures

PrimaryEngagement in Recommended Behaviors to Prevent Type 2 Diabetes

The investigators will use survey and medical record data to evaluate changes in participants' engagement in recommended behaviors to prevent type 2 diabetes.

Time frame:
3 months
Reported as:
Count of participants · Participants
Engagement in Recommended Behaviors to Prevent Type 2 Diabetes
ParticipantsArm 1: Stock Messages OnlyArm 2: Urgency Frame Message StrategyArm 3: Social Norm Message StrategyArm 4: Urgency Frame and Social Norm StrategiesArm 5: Implementation Intentions and Urgency FrameArm 6: Implementation Intentions and Social NormArm 7: Implementation Intentions, Urgency Frame & Social NormArm 8: Implementation IntentionsArm 9: Preference Checklists and Urgency FrameArm 10: Preference Checklists and Social NormsArm 11: Preference Checklists, Urgency Frame & Social NormArm 12: Preference ChecklistsArm 13: Tailored Aspirations and Urgency FrameArm 14: Tailored Aspirations and Social NormArm 15: Tailored Aspirations, Urgency Frame & Social NormArm 16: Tailored Aspirations
Engaged in recommended behaviors2552232264242240
Did not engage in recommended behaviors6447657535755657
Unknown1000110200002102
SecondaryMotivation to Prevent Type 2 Diabetes

The investigators will use survey data to evaluate mean change in motivation level to prevent diabetes between baseline and 3-months. The Treatment Self-Regulation Questionnaire (TSRQ) was included in the survey and respondents were asked about their level of motivation from 1 (Not at all motivated) to 10 (Highly motivated).

Time frame:
3 months
Reported as:
Mean · Score on a scale
Motivation to Prevent Type 2 Diabetes
Score on a scaleArm 1: Stock Messages OnlyArm 2: Urgency Frame Message StrategyArm 3: Social Norm Message StrategyArm 4: Urgency Frame and Social Norm StrategiesArm 5: Implementation Intentions and Urgency FrameArm 6: Implementation Intentions and Social NormArm 7: Implementation Intentions, Urgency Frame & Social NormArm 8: Implementation IntentionsArm 9: Preference Checklists and Urgency FrameArm 10: Preference Checklists and Social NormsArm 11: Preference Checklists, Urgency Frame & Social NormArm 12: Preference ChecklistsArm 13: Tailored Aspirations and Urgency FrameArm 14: Tailored Aspirations and Social NormArm 15: Tailored Aspirations, Urgency Frame & Social NormArm 16: Tailored Aspirations
Motivation to Prevent Type 2 Diabetes.375 ± 2.326-1.222 ± 2.438-0.444 ± 1.333-0.222 ± 1.3940.429 ± 2.2250.000 ± 0.70710.333 ± 1.500-1.143 ± 2.673-2.000 ± 3.122-0.666 ± 1.323-0.333 ± 2.540-0.222 ± 1.986-1.166 ± 1.472-0.286 ± 0.9512-0.555 ± 1.3330.857 ± 2.116
SecondaryImportance of Preventing Type 2 Diabetes

The investigators will use survey data to evaluate mean changes in level of importance of preventing diabetes from baseline to 3 months. The Treatment Self-Regulation Questionnaire (TSRQ) was included in the survey and respondents were asked about their level of perceived importance from 1 (Not at all important) to 10 (Extremely important).

Time frame:
3 months
Reported as:
Mean · Score on a scale
Importance of Preventing Type 2 Diabetes
Score on a scaleArm 1: Stock Messages OnlyArm 2: Urgency Frame Message StrategyArm 3: Social Norm Message StrategyArm 4: Urgency Frame and Social Norm StrategiesArm 5: Implementation Intentions and Urgency FrameArm 6: Implementation Intentions and Social NormArm 7: Implementation Intentions, Urgency Frame & Social NormArm 8: Implementation IntentionsArm 9: Preference Checklists and Urgency FrameArm 10: Preference Checklists and Social NormsArm 11: Preference Checklists, Urgency Frame & Social NormArm 12: Preference ChecklistsArm 13: Tailored Aspirations and Urgency FrameArm 14: Tailored Aspirations and Social NormArm 15: Tailored Aspirations, Urgency Frame & Social NormArm 16: Tailored Aspirations
Importance of Preventing Type 2 Diabetes-0.625 ± 1.847-0.889 ± 2.028-0.444 ± 1.740-0.222 ± 1.5630.714 ± 2.4300.000 ± 0.500-0.500 ± 2.000-1.571 ± 2.070-1.111 ± 2.934-0.333 ± 1.118-0.667 ± 2.0000.667 ± 1.936-0.333 ± 2.5820.429 ± 0.976-2.333 ± 2.2360.286 ± 1.254
SecondaryUse of Medication for T2DM Prevention

The investigators will use medical record data and survey data to evaluate whether participants began the use of medication for T2DM prevention from baseline to 3 months.

Time frame:
3 months
Reported as:
Count of participants · Participants
Use of Medication for T2DM Prevention
ParticipantsArm 1: Stock Messages OnlyArm 2: Urgency Frame Message StrategyArm 3: Social Norm Message StrategyArm 4: Urgency Frame and Social Norm StrategiesArm 5: Implementation Intentions and Urgency FrameArm 6: Implementation Intentions and Social NormArm 7: Implementation Intentions, Urgency Frame & Social NormArm 8: Implementation IntentionsArm 9: Preference Checklists and Urgency FrameArm 10: Preference Checklists and Social NormsArm 11: Preference Checklists, Urgency Frame & Social NormArm 12: Preference ChecklistsArm 13: Tailored Aspirations and Urgency FrameArm 14: Tailored Aspirations and Social NormArm 15: Tailored Aspirations, Urgency Frame & Social NormArm 16: Tailored Aspirations
Taking medication0110000000000010
Not taking medication7889889799897887
Unknown2000110200102102
SecondaryPerception for Risk for T2DM

The investigators will use survey data to evaluate mean changes in perception of risk for T2DM from baseline to 3 months. The Adriaanse T2DM Risk Perception Scale, which was included in the survey, measured self-assessed risk perception from 0 denoting no choice of developing T2DM to 100 denoting absolute confidence in developing T2DM

Time frame:
3 months
Reported as:
Mean · Score on a scale
Perception for Risk for T2DM
Score on a scaleArm 1: Stock Messages OnlyArm 2: Urgency Frame Message StrategyArm 3: Social Norm Message StrategyArm 4: Urgency Frame and Social Norm StrategiesArm 5: Implementation Intentions and Urgency FrameArm 6: Implementation Intentions and Social NormArm 7: Implementation Intentions, Urgency Frame & Social NormArm 8: Implementation IntentionsArm 9: Preference Checklists and Urgency FrameArm 10: Preference Checklists and Social NormsArm 11: Preference Checklists, Urgency Frame & Social NormArm 12: Preference ChecklistsArm 13: Tailored Aspirations and Urgency FrameArm 14: Tailored Aspirations and Social NormArm 15: Tailored Aspirations, Urgency Frame & Social NormArm 16: Tailored Aspirations
Perception for Risk for T2DM-8.750 ± 8.345-1.111 ± 13.6426.667 ± 15.000-4.444 ± 13.3330.000 ± 17.3211.111 ± 9.280-5.556 ± 40.03510.000 ± 20.0007.778 ± 24.889-3.333 ± 11.1808.333 ± 24.238-2.222 ± 28.6265.000 ± 25.10010.000 ± 21.6023.333 ± 33.16610.000 ± 25.166
SecondaryKnowledge of Strategies to Prevent T2DM

The investigators will use survey data to evaluate changes in knowledge of strategies to prevent Type 2 Diabetes between baseline and 3-month assessment. Respondents were given 3 open-ended questions to report things they could do to prevent diabetes. Each respective response to the 3 questions were coded and scored according to whether they indicated engagement in the following activities: weight loss, physical activity, use of metformin, or enrollment into a diabetes prevention program. Each question denoted with a positive response were coded with 1 whereas those that did not were coded as a 0. The three questions were summed into a final score ranging from 0 (no report of engagement in the aforementioned healthy activities) with the worst outcome to 3 (a report of 3 of the 4 aforementioned healthy activities) with the best outcome. The final scores were generated based on the mean difference between baseline and 3-month scores.

Time frame:
3 months
Reported as:
Mean · Score on a scale
Knowledge of Strategies to Prevent T2DM
Score on a scaleArm 1: Stock Messages OnlyArm 2: Urgency Frame Message StrategyArm 3: Social Norm Message StrategyArm 4: Urgency Frame and Social Norm StrategiesArm 5: Implementation Intentions and Urgency FrameArm 6: Implementation Intentions and Social NormArm 7: Implementation Intentions, Urgency Frame & Social NormArm 8: Implementation IntentionsArm 9: Preference Checklists and Urgency FrameArm 10: Preference Checklists and Social NormsArm 11: Preference Checklists, Urgency Frame & Social NormArm 12: Preference ChecklistsArm 13: Tailored Aspirations and Urgency FrameArm 14: Tailored Aspirations and Social NormArm 15: Tailored Aspirations, Urgency Frame & Social NormArm 16: Tailored Aspirations
Knowledge of Strategies to Prevent T2DM0 ± 1.069-0.222 ± 0.667-0.222 ± 0.833-0.222 ± 0.9720.125 ± 0.641-0.444 ± 0.8820.444 ± 0.7260.429 ± 0.5350.333 ± 0.8660.333 ± 0.7070.889 ± 0.928-0.333 ± 0.5000.143 ± 0.3780 ± 0.5350.778 ± 0.8330.286 ± 0.488
SecondaryParticipation in Weight-related Wellness Programs

The investigators will use survey data to evaluate how many participants enrolled in weight-related wellness programs from baseline to 3 months.

Time frame:
3 months
Reported as:
Count of participants · Participants
Participation in Weight-related Wellness Programs
ParticipantsArm 1: Stock Messages OnlyArm 2: Urgency Frame Message StrategyArm 3: Social Norm Message StrategyArm 4: Urgency Frame and Social Norm StrategiesArm 5: Implementation Intentions and Urgency FrameArm 6: Implementation Intentions and Social NormArm 7: Implementation Intentions, Urgency Frame & Social NormArm 8: Implementation IntentionsArm 9: Preference Checklists and Urgency FrameArm 10: Preference Checklists and Social NormsArm 11: Preference Checklists, Urgency Frame & Social NormArm 12: Preference ChecklistsArm 13: Tailored Aspirations and Urgency FrameArm 14: Tailored Aspirations and Social NormArm 15: Tailored Aspirations, Urgency Frame & Social NormArm 16: Tailored Aspirations
Participation in weight-related wellness programs0000100000010010
No participation in weight-related wellness programs8999789799987887
Unknown1000110200002102
SecondaryWeight Loss Behaviors

The investigators will use survey data to evaluate changes in weight loss behaviors at the 3-month post intervention assessment.

Time frame:
3 months
Reported as:
Count of participants · Participants
Weight Loss Behaviors
ParticipantsArm 1: Stock Messages OnlyArm 2: Urgency Frame Message StrategyArm 3: Social Norm Message StrategyArm 4: Urgency Frame and Social Norm StrategiesArm 5: Implementation Intentions and Urgency FrameArm 6: Implementation Intentions and Social NormArm 7: Implementation Intentions, Urgency Frame & Social NormArm 8: Implementation IntentionsArm 9: Preference Checklists and Urgency FrameArm 10: Preference Checklists and Social NormsArm 11: Preference Checklists, Urgency Frame & Social NormArm 12: Preference ChecklistsArm 13: Tailored Aspirations and Urgency FrameArm 14: Tailored Aspirations and Social NormArm 15: Tailored Aspirations, Urgency Frame & Social NormArm 16: Tailored Aspirations
Losing weight2552342344251410
Gaining weight1000001010001010
Stable and satisfied0201111010010011
Stable and lose5246435335735366
Stable and gain0000000100000100
Unknown1000110200002102
SecondaryPhysical Activity

The investigators will use survey data to evaluate changes in physical activity after the 3-month post intervention assessment. The International Physical Activity Questionnaire - Short Form (IPAQ-SF) was used to measure physical activity change. Respondents were asked to report how many hours and minutes within the past week they completed of vigorous physical activity, moderate physical activity, and brisk walking. The total sum of minutes for these three questions were subsequently coded into a yes/no binary variable for whether respondents met a recommended 150 minutes of overall physical activity within 7 days of being assessed. The values provided reflect a proportion of respondents that met or exceeded the 150 minute threshold of overall physical activity based on the newly generated variable that combined total minutes of vigorous physical activity, moderate physical activity, and brisk walking.

Time frame:
3 months
Reported as:
Count of participants · Participants
Physical Activity
ParticipantsArm 1: Stock Messages OnlyArm 2: Urgency Frame Message StrategyArm 3: Social Norm Message StrategyArm 4: Urgency Frame and Social Norm StrategiesArm 5: Implementation Intentions and Urgency FrameArm 6: Implementation Intentions and Social NormArm 7: Implementation Intentions, Urgency Frame & Social NormArm 8: Implementation IntentionsArm 9: Preference Checklists and Urgency FrameArm 10: Preference Checklists and Social NormsArm 11: Preference Checklists, Urgency Frame & Social NormArm 12: Preference ChecklistsArm 13: Tailored Aspirations and Urgency FrameArm 14: Tailored Aspirations and Social NormArm 15: Tailored Aspirations, Urgency Frame & Social NormArm 16: Tailored Aspirations
150 minutes or more physical activity per week5467456667683642
Less than 150 minutes or more of physical activity per week4532543332316357

Adverse events

Collected over 3-months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Arm 1: Stock Messages Only0/9 (0%)0/9 (0%)0/9 (0%)
Arm 2: Urgency Frame Message Strategy0/9 (0%)0/9 (0%)0/9 (0%)
Arm 3: Social Norm Message Strategy0/9 (0%)0/9 (0%)0/9 (0%)
Arm 4: Urgency Frame and Social Norm Strategies0/9 (0%)0/9 (0%)0/9 (0%)
Arm 5: Implementation Intentions and Urgency Frame0/9 (0%)0/9 (0%)0/9 (0%)
Arm 6: Implementation Intentions and Social Norm0/9 (0%)0/9 (0%)0/9 (0%)
Arm 7: Implementation Intentions, Urgency Frame & Social Norm0/9 (0%)0/9 (0%)0/9 (0%)
Arm 8: Implementation Intentions0/9 (0%)0/9 (0%)0/9 (0%)
Arm 9: Preference Checklists and Urgency Frame0/9 (0%)0/9 (0%)0/9 (0%)
Arm 10: Preference Checklists and Social Norms0/9 (0%)0/9 (0%)0/9 (0%)
Arm 11: Preference Checklists, Urgency Frame & Social Norm0/9 (0%)0/9 (0%)0/9 (0%)
Arm 12: Preference Checklists0/9 (0%)0/9 (0%)0/9 (0%)
Arm 13: Tailored Aspirations and Urgency Frame0/9 (0%)0/9 (0%)0/9 (0%)
Arm 14: Tailored Aspirations and Social Norm0/9 (0%)0/9 (0%)0/9 (0%)
Arm 15: Tailored Aspirations, Urgency Frame & Social Norm0/9 (0%)0/9 (0%)1/9 (11.1%)
Arm 16: Tailored Aspirations0/9 (0%)0/9 (0%)0/9 (0%)
Most frequent other events
Most frequent other events
EventArm 1: Stock Messages OnlyArm 2: Urgency Frame Message StrategyArm 3: Social Norm Message StrategyArm 4: Urgency Frame and Social Norm StrategiesArm 5: Implementation Intentions and Urgency FrameArm 6: Implementation Intentions and Social NormArm 7: Implementation Intentions, Urgency Frame & Social NormArm 8: Implementation IntentionsArm 9: Preference Checklists and Urgency FrameArm 10: Preference Checklists and Social NormsArm 11: Preference Checklists, Urgency Frame & Social NormArm 12: Preference ChecklistsArm 13: Tailored Aspirations and Urgency FrameArm 14: Tailored Aspirations and Social NormArm 15: Tailored Aspirations, Urgency Frame & Social NormArm 16: Tailored Aspirations
Diagnosis of CancerNeoplasms benign, malignant and unspecified (incl cysts and polyps)0/90/90/90/90/90/90/90/90/90/90/90/90/90/91/90/9

Baseline characteristics

Enrolled study participants with a diagnosis of prediabetes that were randomized to 1 of 16 study arms.

Age, Categorical
Age, Categorical(Participants)Arm 1: Stock Messages OnlyArm 2: Urgency Frame Message StrategyArm 3: Social Norm Message StrategyArm 4: Urgency Frame and Social Norm StrategiesArm 5: Implementation Intentions and Urgency FrameArm 6: Implementation Intentions and Social NormArm 7: Implementation Intentions, Urgency Frame & Social NormArm 8: Implementation IntentionsArm 9: Preference Checklists and Urgency FrameArm 10: Preference Checklists and Social NormsArm 11: Preference Checklists, Urgency Frame & Social NormArm 12: Preference ChecklistsArm 13: Tailored Aspirations and Urgency FrameArm 14: Tailored Aspirations and Social NormArm 15: Tailored Aspirations, Urgency Frame & Social NormArm 16: Tailored AspirationsTotal
<=18 years00000000000000000
Between 18 and 65 years523473676463447374
>=65 years476526323536552670
Age, Continuous
Age, Continuous(Years)Arm 1: Stock Messages OnlyArm 2: Urgency Frame Message StrategyArm 3: Social Norm Message StrategyArm 4: Urgency Frame and Social Norm StrategiesArm 5: Implementation Intentions and Urgency FrameArm 6: Implementation Intentions and Social NormArm 7: Implementation Intentions, Urgency Frame & Social NormArm 8: Implementation IntentionsArm 9: Preference Checklists and Urgency FrameArm 10: Preference Checklists and Social NormsArm 11: Preference Checklists, Urgency Frame & Social NormArm 12: Preference ChecklistsArm 13: Tailored Aspirations and Urgency FrameArm 14: Tailored Aspirations and Social NormArm 15: Tailored Aspirations, Urgency Frame & Social NormArm 16: Tailored AspirationsTotal
Mean57.3 ± 13.466 ± 8.362.1 ± 13.162.1 ± 8.955.6 ± 10.264.2 ± 9.063.3 ± 5.857.4 ± 10.962.4 ± 5.560.1 ± 10.362.1 ± 6.464.7 ± 9.063.1 ± 9.961.2 ± 10.057.1 ± 7.661.6 ± 11.361.3 ± 9.4
Sex/Gender, Customized
Sex/Gender, Customized(Participants)Arm 1: Stock Messages OnlyArm 2: Urgency Frame Message StrategyArm 3: Social Norm Message StrategyArm 4: Urgency Frame and Social Norm StrategiesArm 5: Implementation Intentions and Urgency FrameArm 6: Implementation Intentions and Social NormArm 7: Implementation Intentions, Urgency Frame & Social NormArm 8: Implementation IntentionsArm 9: Preference Checklists and Urgency FrameArm 10: Preference Checklists and Social NormsArm 11: Preference Checklists, Urgency Frame & Social NormArm 12: Preference ChecklistsArm 13: Tailored Aspirations and Urgency FrameArm 14: Tailored Aspirations and Social NormArm 15: Tailored Aspirations, Urgency Frame & Social NormArm 16: Tailored AspirationsTotal
Male9888787886699997126
Female001121211330000217
Transgender01000000000000001
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Arm 1: Stock Messages OnlyArm 2: Urgency Frame Message StrategyArm 3: Social Norm Message StrategyArm 4: Urgency Frame and Social Norm StrategiesArm 5: Implementation Intentions and Urgency FrameArm 6: Implementation Intentions and Social NormArm 7: Implementation Intentions, Urgency Frame & Social NormArm 8: Implementation IntentionsArm 9: Preference Checklists and Urgency FrameArm 10: Preference Checklists and Social NormsArm 11: Preference Checklists, Urgency Frame & Social NormArm 12: Preference ChecklistsArm 13: Tailored Aspirations and Urgency FrameArm 14: Tailored Aspirations and Social NormArm 15: Tailored Aspirations, Urgency Frame & Social NormArm 16: Tailored AspirationsTotal
Hispanic or Latino00120000011000005
Not Hispanic or Latino9987999998899999139
Unknown or Not Reported00000000000000000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Arm 1: Stock Messages OnlyArm 2: Urgency Frame Message StrategyArm 3: Social Norm Message StrategyArm 4: Urgency Frame and Social Norm StrategiesArm 5: Implementation Intentions and Urgency FrameArm 6: Implementation Intentions and Social NormArm 7: Implementation Intentions, Urgency Frame & Social NormArm 8: Implementation IntentionsArm 9: Preference Checklists and Urgency FrameArm 10: Preference Checklists and Social NormsArm 11: Preference Checklists, Urgency Frame & Social NormArm 12: Preference ChecklistsArm 13: Tailored Aspirations and Urgency FrameArm 14: Tailored Aspirations and Social NormArm 15: Tailored Aspirations, Urgency Frame & Social NormArm 16: Tailored AspirationsTotal
American Indian or Alaska Native00000011000000013
Asian00000000000000000
Native Hawaiian or Other Pacific Islander00000000000000000
Black or African American01110100101102009
White8887788688877688120
More than one race10002002000121009
Unknown or Not Reported00010000010000103
Region of Enrollment
Region of Enrollment(participants)Arm 1: Stock Messages OnlyArm 2: Urgency Frame Message StrategyArm 3: Social Norm Message StrategyArm 4: Urgency Frame and Social Norm StrategiesArm 5: Implementation Intentions and Urgency FrameArm 6: Implementation Intentions and Social NormArm 7: Implementation Intentions, Urgency Frame & Social NormArm 8: Implementation IntentionsArm 9: Preference Checklists and Urgency FrameArm 10: Preference Checklists and Social NormsArm 11: Preference Checklists, Urgency Frame & Social NormArm 12: Preference ChecklistsArm 13: Tailored Aspirations and Urgency FrameArm 14: Tailored Aspirations and Social NormArm 15: Tailored Aspirations, Urgency Frame & Social NormArm 16: Tailored AspirationsTotal
United States9999999999999999144
07

Study locations

1 site
  • VA Ann Arbor Healthcare System, Ann Arbor, MI
    Ann Arbor, Michigan 48105-2303, United States
08

References and documents

Study documents

  • Study protocol · Mar 15, 2021

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Registry details

Key details

Study ID
NCT03403231
Lead sponsor
VA Office of Research and Development
Responsible party
Sponsor
First posted
Jan 18, 2018
Start date
Feb 1, 2018
Primary completion
Mar 1, 2020
Completion
Sep 30, 2020
Results posted
Jun 16, 2021
Last update
Jul 25, 2023

Study contacts

Jeffrey T. Kullgren, MD MPH MS
principal investigator · VA Ann Arbor Healthcare System, Ann Arbor, MI

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion